Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

DPP may help hair regrowth by improving blood vessel function under stress.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

DA-9401 helps protect rat testis from finasteride damage.

Y-27632 helps hair follicle stem cells grow and keep their abilities.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.